A new wearable device for continuous dialysis treatment
Novel Sheet-Membrane Dialyzer for Wearable Hemodialysis
This study is testing a new, smaller wearable dialysis device that uses super-thin membranes to help people with End Stage Renal Disease clean their blood more effectively, giving them the freedom to manage their treatment in a way that fits better into their daily lives.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10874664 on NIH RePORTER |
What this research studies
This research focuses on developing a novel wearable hemodialysis system that utilizes ultrathin nanoporous membranes to improve the efficiency of toxin removal in patients with End Stage Renal Disease (ESRD). By creating a smaller and more efficient device, the goal is to allow patients to undergo continuous dialysis in a more flexible manner, enhancing their quality of life. The approach involves using advanced silicon-based membranes that are significantly thinner than traditional dialysis membranes, which could lead to better clinical outcomes. Patients will benefit from more frequent and effective dialysis without the constraints of conventional center-based treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with End Stage Renal Disease who require regular dialysis treatment.
Not a fit: Patients with early-stage kidney disease or those who do not require dialysis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide ESRD patients with a more convenient and effective way to manage their condition through continuous dialysis.
How similar studies have performed: Previous research has shown promise in developing wearable dialysis systems, but this approach with ultrathin membranes is relatively novel and untested.
Where this research is happening
Rochester, United States
- University of Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Johnson, Dean G — University of Rochester
- Study coordinator: Johnson, Dean G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.